Platelet reactivity on brand and generic clopidogrel chronic therapy
Introduction: Generic drugs are approved when they are shown to be bio-equivalent in their pharmacokinetic profiles. Whether the pharmacological effect of the generic formulation is similar to the brand is not always easy to see if there is no observable physiological effect of the drug. ADP multipl...
Main Authors: | Shukri AlSaif, Ali Bayoumi, Mohamed AlQasem, Jessie Aubeg, Raja Aljumaian, Reshmi George, Robelyn Corbita, Ali Youssef, Sayed Abdou, Ahmad AlQudaimi, Ahmad Soliman |
---|---|
Format: | Article |
Language: | English |
Published: |
Saudi Heart Association
2018-10-01
|
Series: | Journal of the Saudi Heart Association |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1016731518301635 |
Similar Items
-
Effect of original and generic clopidogrel on prognosis in relation to different gene polymorphisms
by: D F Mesitskaia, et al.
Published: (2014-09-01) -
In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris
by: Rza Hajizadeh, et al.
Published: (2017-12-01) -
Withdrawal of two generic clopidogrel products in Saudi Arabia for non-bio-equivalence
by: Abdullah Saleh Alsultan, et al.
Published: (2018-05-01) -
The impact of generic form of Clopidogrel on cardiovascular events in patients with coronary artery stent: results of the OPCES study
by: Ali Reza Khosravi, et al.
Published: (2011-01-01) -
COMPARISON OF THE ORIGINAL (PLAVIx) AND GENERIC (CLAPITAx) CLOPIDOGREL ON PLATELET AGGREGATION: ObSERVATIONAL STUDY
by: A. S. Skotnikov, et al.
Published: (2018-05-01)